News + Filings Holdings
All
13F
13D/G
Other
|
|
Decheng Capital Management III (Cayman), LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/08/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/27/2022 |
4
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 639,456 shares
@ $7.35, valued at
$4.7M
Granted 1,360,544 shares
@ $7.35, valued at
$10M
|
|
| 08/01/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G
| Decheng Capital Management III , LLC reports a 15.1% stake in Equillium Inc. |
| 02/14/2022 |
SC 13G
| Decheng Capital Management III , LLC reports a 6.2% stake in Checkmate Pharamaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| Decheng Capital Management III , LLC reports a 12.7% stake in BeyondSpring Inc. |
| 02/14/2022 |
SC 13G
| Decheng Capital Management III , LLC reports a 16.1% stake in Alpine Immune Sciences, Inc. |
| 02/14/2022 |
SC 13G
| Decheng Capital Management III , LLC reports a 6.1% stake in Cue Health Inc. |
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
3
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
|
|